MMRF Accelerator Magazine Winter 2015 Edition | Page 11

If you have any questions about the clinical trials that have been initiated over the last 18 months, or believe you may be eligible, please call our nurse hotline at 1-866-603-6628. first trial on a class of drugs known as immune checkpoint inhibitors which patients with high risk SMM. It is with these results that Dr. Ghobrial seeks to investigate adding a novel biological Dr. Jeff Zon